United Health Products Inc. Announces Optimal Government Services as UHP's Exclusive Government Distributor

HENDERSON, NV--(Marketwired - Jan 21, 2016) - United Health Products Inc. (OTCQB: UEEC) announced that it has entered into a contract with Optimal Government Resources as the exclusive government distributor for its HemoStyp® product line. Douglas Beplate, CEO of United Health Products Inc., added, "We are very pleased to be working with Optimal GS and to provide our HemoStyp® products to the U.S. Military and other U.S. Government agencies." The contract outlines the addition of HemoStyp® products to Optimal's ERP, Service Order Module, included in the existing DAPA MS contract, registered in the Military and DOD Prime Vendor catalogs and assigned number registry with the Prime Vendor.

About Optimal

Optimal GS is a participant in the Department of Defense and Department of Veterans Affairs Medical/Surgical Prime Vendor Programs (MSPV), and the DOD and VA Pharmaceutical Prime Vendor Program (PPV). Optimal has commercial agreements with the National and Regional Prime Vendors to ensure highly efficient national distribution of its products to its Federal Customer Base. Optimal GS specializes in moving medical product through this network.

About United Health Products Inc.

United Health Products Inc. (UEEC) develops, manufactures, and markets patented hemostatic gauze, for the healthcare and wound care sectors. The product, HemoStyp®, is derived from regenerated oxidized cellulose, which is all natural, and designed to absorb exudate/drainage from superficial wounds and helps control bleeding. UEEC is focused on identifying new markets and applications for its products, and expanding its current markets. For more on United Health Products Inc. visit: www.unitedhealthproductsinc.com

Safe Harbor Statement

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release may contain forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipates" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements.